- Home
- ANIX vs GECC Comparison
ANIX vs GECC Comparison
Compare ANIX & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANIX | GECC |
|---|---|---|
| Founded | 1982 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 101.8M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANIX | GECC |
|---|---|---|
| Price | $2.99 | $6.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $9.00 | ★ $10.75 |
| AVG Volume (30 Days) | ★ 244.6K | 56.2K |
| Earning Date | 03-10-2026 | 03-09-2026 |
| Dividend Yield | N/A | ★ 23.25% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $46,553,000.00 |
| Revenue This Year | N/A | $32.31 |
| Revenue Next Year | N/A | $1.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.68 |
| 52 Week Low | $2.33 | $6.45 |
| 52 Week High | $5.46 | $11.46 |
Technical Indicators
Market Signals| Indicator | ANIX | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 36.09 |
| Support Level | $2.75 | $6.45 |
| Resistance Level | $3.09 | $7.32 |
| Average True Range (ATR) | 0.15 | 0.22 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 5.00 | 14.69 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.